Invesco’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519K | Buy |
34,680
+9,473
| +38% | +$142K | ﹤0.01% | 3140 |
|
|
2025
Q1 | $407K | Buy |
25,207
+5,544
| +28% | +$89.5K | ﹤0.01% | 3226 |
|
|
2024
Q4 | $458K | Sell |
19,663
-118,195
| -86% | -$2.75M | ﹤0.01% | 3259 |
|
|
2024
Q3 | $4.05M | Buy |
137,858
+121,494
| +742% | +$3.57M | ﹤0.01% | 2336 |
|
|
2024
Q2 | $385K | Sell |
16,364
-136,214
| -89% | -$3.2M | ﹤0.01% | 3378 |
|
|
2024
Q1 | $5.79M | Buy |
+152,578
| New | +$5.79M | ﹤0.01% | 2134 |
|
|
2022
Q2 | – | Sell |
-494
| Closed | -$29K | – | 4103 |
|
|
2022
Q1 | $29K | Buy |
494
+6
| +1% | +$352 | ﹤0.01% | 3930 |
|
|
2021
Q4 | $58K | Sell |
488
-101
| -17% | -$12K | ﹤0.01% | 3929 |
|
|
2021
Q3 | $117K | Buy |
589
+67
| +13% | +$13.3K | ﹤0.01% | 3876 |
|
|
2021
Q2 | $90K | Buy |
+522
| New | +$90K | ﹤0.01% | 3880 |
|
|
2020
Q3 | – | Sell |
-2,507
| Closed | -$580K | – | 3644 |
|
|
2020
Q2 | $580K | Buy |
+2,507
| New | +$580K | ﹤0.01% | 3049 |
|
|
2018
Q4 | – | Sell |
-1,053
| Closed | -$252K | – | 3804 |
|
|
2018
Q3 | $252K | Sell |
1,053
-390
| -27% | -$93.3K | ﹤0.01% | 3595 |
|
|
2018
Q2 | $382K | Buy |
+1,443
| New | +$382K | ﹤0.01% | 3502 |
|